查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1146329

醫療用品市場 - 增長、趨勢、COVID-19 的影響、預測 (2022-2027)

Medical Supplies Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

醫療用品市場預計在 2022-2027 年的預測期內復合年增長率為 3.4%。

COVID-19 大流行對市場產生了各種影響。當前，各國繼續面臨大流行病的巨大威脅。 COVID-19 造成的供應鏈中斷導致全球關鍵醫療用品短缺。因此，許多國家已採取明確措施進口商品以緩解短缺。

據 FDA 稱，2022 年 7 月，由於 COVID-19 大流行，州聯邦政府實施了多項限制措施。 《聯邦食品、藥品和化妝品法》（FD&C 法）第 506J 節反映了食品藥品監督管理局 (FDA) 確定在 COVID-19 公共衛生緊急事件期間供不應求的設備類別。隨著它的發展而更新。供不應求的主要醫療用品是“透析相關產品”、“個人防護設備”、“檢測用品和設備”以及“呼吸相關產品”。這種短缺導致對醫療用品的高需求，對市場做出了重大貢獻。

根據 2022 年 1 月發布的 Kauffman Hall National Hospital Bulletin，從 2019 年到 2021 年，醫療用品短缺將使每位患者的住院費用增加 20.6%。最近由 Delta 和 Omicron 變體引起的激增進一步增加了醫院的壓力。採用次優替代品是醫院供應鍊網絡中的一個主要問題。大流行後，公司可以考慮採用增材製造等現代生產技術來減少對產品的依賴。在大流行之前，準時制 (JIT) 政策是製造業的常態。在準時制政策下，供應鏈代理很少在供應鍊網絡內維護成品和原材料的庫存。但是，洗手液和衛生紙等部分產品的需求激增。因此，企業面臨著原材料和產能的嚴重短缺。因此，上述 COVID-19 響應表明，雖然 JIT 可能會降低庫存成本，但在危機情況下並不合適。因此，在後疫情時代，將有必要將採購策略從全球轉向本地。供應鏈經理採取措施改變全球採購方式，並在生產地點附近尋找和推廣當地質量相同的原材料來源。因此，不僅是全球玩家，本土玩家之間的競爭也越來越激烈。因此，預計在大流行後期間該地區對醫療用品的需求將會增加。

慢性病是最常見的健康狀況，需要花費大量金錢。慢性病包括癌症、糖尿病、高血壓、中風、心髒病、呼吸系統疾病、關節炎和肥胖症，這些疾病可能導致住院、長期殘疾、生活質量低下，甚至死亡。根據世界衛生組織 (WHO) 的數據，到 2021 年全球將有大約 4.22 億人患上糖尿病，每年有 150 萬人直接死於糖尿病。在過去的幾十年裡，糖尿病的患病率和患病率都在穩步上升。根據 2021 年 8 月發布的《第一次全球高血壓患病率、檢測、治療和控制趨勢綜合分析》，在過去 30 年中，患有高血壓的 30 至 79 歲成年人佔 6 億。據說從 50億至 12.8 億。由於慢性病、生活方式相關疾病和傷害的增加，對醫療用品的需求非常高。對市場供應的高需求正在推動市場增長。

因此，上述因素共同歸因於預測期內研究的市場增長。然而，嚴格的監管框架預計將阻礙預測期內的市場增長。

主要市場趨勢

在預測期內，導管部分有望實現高速增長

導管是一種細而柔韌的管子，可讓您從體內註入和抽出液體。導管有五種類型：心血管導管、靜脈導管、導尿管、特種導管和神經血管導管。導管被發現佔有最大份額，這可能歸因於心血管疾病發病率的上升和全球導管相關手術數量的增加。根據 2020 年美國人口普查局的一份報告，預計從 2025 年到 2060 年，所有四種心血管危險因素都會增加，其中糖尿病增加最快（增加 39.3% 至 55 億），其次是血脂異常（增加 27.6% 至 1.26 億），高血壓（上升 25.1% 至 1.62 億）和肥胖症（上升 18.3% 至 1.26 億）。我來了。根據美國疾病控制與預防中心（CDC）的數據，2020 年心髒病將在美國奪去約 697,000 人的生命，其中冠心病最為常見，全美有 382,□□820 人死亡，約 805,000 人心髒病發作每年。據說它正在造成隨著與膀胱相關的慢性疾病、心血管疾病和其他疾病患病率的增加，這些疾病是推動增長的主要因素。此外，由於疾病及其治療方法的流行，患者對微創手術的需求不斷增加，這進一步推動了這一領域的增長。

北美有望主導醫療用品市場

由於產品創新的高年度投資和現有技術的不斷改進等因素，預計北美將主導市場。北美最大的市場是美國。

美國醫療用品行業是醫療保健行業的重要組成部分。該市場與Johnson & Johnson Services, Inc、Abbott和Baxter International Inc.等醫療用品市場的主要參與者競爭激烈。根據美國癌症協會 2021 年的數據，約有 190 萬例新發癌症被診斷出來，其中包括 268,490 例前列腺癌、287,850 例浸潤性乳腺癌、236,740 例肺癌和 106,180 例結直腸癌。預計這些趨勢將推動未來的市場增長。

因此，由於上述因素，預計北美地區的市場增長。

競爭格局

由於多家公司在全球和區域運營，醫療用品市場在本質上是分散的。競爭格局包括 Medtronic plc、Cardinal Health、Becton、Dickinson and Company、Johnson & Johnson Services, Inc、B. Braun Melsungen AG、Boston Scientific Corporation、Thermo Fisher Scientific, Inc、Baxter、3M Company、Smith & Nephew 它包括分析多家具有市場份額的知名國際和本地公司，例如：

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 慢性病患病率增加
    • 醫療事故數量增加
    • 醫院和外科中心的手術數量和 ICU 入院人數增加
    • 政府補貼醫療費用的努力
  • 市場製約因素
    • 產品召回
    • 國家級醫療器械法規
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品類型
    • 診斷耗材
    • 輸液和注射用品
    • 插管和通氣用品
    • 消毒劑
    • 個人防護裝備
    • 滅菌耗材
    • 傷口護理耗材
    • 透析相關耗材
    • 輻射相關消耗品
    • 導管
    • 其他醫療器械
  • 通過申請
    • 泌尿科
    • 傷口敷料
    • 放射科
    • 呼吸科
    • 感染控制
    • 心髒病學
    • 體外診斷
    • 其他用途
  • 最終用戶
    • 醫院
    • 診所和診所
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Medtronic plc
    • Cardinal Health
    • Becton, Dickinson and Company
    • Johnson & Johnson Services, Inc.
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • Thermo Fisher Scientific, Inc.
    • Baxter
    • 3M Company
    • Smith & Nephew
    • Abbott
    • Convatec Inc.
    • Cook Medical
    • Stryker
    • Hamilton Medical

第七章市場機會與未來趨勢

簡介目錄
Product Code: 91905

The Medical Supplies Market is expected to register a CAGR of 3.4% over the forecast period, 2022-2027. The COVID-19 pandemic had a mixed impact on the market. Currently, countries continue to face the huge threat of the pandemic. The supply chain disruption caused due to COVID-19 led to shortages of critical medical supplies worldwide. Therefore, many countries have taken definite measures to ease the shortages by importing supplies.

According to 'FDA,' July 2022, due to the COVID-19 pandemic, several restrictive measures have been implemented by the State federation's governments. Section 506J of the Federal Food, Drug, and Cosmetic Act (FD&C Act) reflects the categories of devices that Food and Drug Administration (FDA) has determined to be in shortage and maintained and updated as the COVID-19 public health emergency evolves. The major medical supplies in shortage are Dialysis-Related Products, Personal Protective Equipment, Testing Supplies and Equipment and Ventilation-Related Products. The shortage led to high demand for medical supplies, significantly contributing to the market.

According to "Kaufman Hall National Hospital Flash Report," published in January 2022, there is an increase of 20.6% in Hospital expenses per patient from 2019 to 2021 caused due to shortage of medical supplies. The most recent surges triggered by the delta and omicron variants have added even more pressure to hospitals. Adoption of suboptimal substitutes is a major issue in supply chain networks in hospitals. Following the pandemic, businesses may consider reducing dependence by implementing modern production techniques like additive manufacturing. Just in Time (JIT) policy was the standard in manufacturing companies prior to the pandemic. Supply chain agents maintain little finished goods or raw material inventory in the supply chain network under a just-in-time policy. But several of the products, including hand sanitizers and toilet paper, saw a sharp rise in demand. Therefore, there was a severe shortage of both raw materials and production capacity for the enterprises. As a result, the above response to COVID-19 implies that, while JIT may provide lower inventory costs, it is not appropriate during times of crisis. Hence, it will be necessary to change the sourcing strategy from global to local in the post-pandemic era. Supply chain managers take steps to change their global sourcing and work to find and promote local sources that offer comparable quality raw materials close to their production facilities. Hence there is high competition among the global as well as local players. Therefore, the post-pandemic period is expected to see an increase in the demand for medical supplies in the region.

Chronic diseases are the most prevalent health condition that involves significant expenditure. Chronic diseases include cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, and obesity, which can lead to hospitalization, long-term disability, reduced quality of life, and even death. According to the World Health Organization (WHO), by 2022 approximately 422 million worldwide have diabetes in 2021, and 1.5 million deaths are directly attributed to diabetes each year. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades. According to the 'first comprehensive global analysis of trends in hypertension prevalence, detection, treatment and control' published in August 2021, the number of adults aged 30-79 years with hypertension has increased from 650 million to 1.28 billion in the last 30 years. The increasing prevalence of chronic and lifestyle diseases, and the high volume of cases of injuries places a great demand for medical supplies products. The high demand for market supplies drives the growth of the market.

Therefore, the factors mentioned above are attributed collectively to the studied market growth over the forecast period. However, a stringent regulatory framework is expected to hinder market growth over the forecast period.

Key Market Trends

Catheter Segment is Expected to Witness High Growth Over the Forecast Period

A catheter is a thin, flexible tube that can put fluids into your body or take them out. There are five types of catheters: cardiovascular catheters, intravenous catheters, urological catheters, specialty catheters and neurovascular catheters. Catheters are found to hold the largest share which can be attributed to the rising incidence of cardiovascular disease and the increasing volume of catheter related surgeries, across the globe. According to the U.S. Census Bureau report, published in 2020, all four cardiovascular risk factors are expected to increase from 2025 to 2060, with the largest percentage increase in diabetes (39.3% increase to 55 million persons), followed by dyslipidemia (27.6% increase to 126 million persons), hypertension (25.1% increase to 162 million persons) and obesity (18.3% increase to 126 million persons). According to Centers for Disease Control and Prevention (CDC) in 2020, about 697,000 people in the United States died from heart disease out of which coronary heart disease is the most common type of heart disease, killing 382,820 people and about 805,000 people in the United States have a heart attack every year. With increase in prevalence of chronic diseases associated with urinary bladder, cardiovascular disease, and others are the major factors that drive the growth. In addition, the increase in demand for minimal invasive surgeries among patients owing to the increase disease prevalence and its treatment further fuels the segment growth.

North America is Expected to Dominate the Medical Supplies Market

North America is expected to dominate the market owing to factors such as higher investment of yearly revenues in product innovation and constant improvement of existing technologies. The United States is the largest market in North America.

The US medical supply sector is an important part of the healthcare industry. The market has a very competitive landscape, with leading medical supply market players, such as Johnson & Johnson, Abbott, and Baxter International. According to the American Cancer Society 2021, about 1.9 million new cancer cases were diagnosed, including 268,490 cases of prostate cancer, 287,850 cases of invasive breast cancer, 236,740 cases of lung cancer, and 106,180 cases of colorectal cancer. These trends are likely to boost the growth of the market in the future.

Therefore, owing to the aforesaid factors the growth of the market studied is anticipated in the North America Region.

Competitive Landscape

The Medical Supplies Market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. include Medtronic plc, Cardinal Health, Becton, Dickinson and Company, Johnson & Johnson Services, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Thermo Fisher Scientific, Inc., Baxter, 3M Company, and Smith & Nephew, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Chronic Disease Prevalence
    • 4.2.2 Rising Number of Medical Emergencies
    • 4.2.3 Increase Number of Surgical Procedure and ICU Admission in Hospital and Surgical Centers
    • 4.2.4 Government Initiative in Healthcare Funding
  • 4.3 Market Restraints
    • 4.3.1 Product Recalls
    • 4.3.2 Country-level Medical Device Regulation
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Diagnostic Supplies
    • 5.1.2 Infusion & Injectable Supplies
    • 5.1.3 Intubation & Ventilation Supplies
    • 5.1.4 Disinfectants
    • 5.1.5 Personal Protective Equipment
    • 5.1.6 Sterilization Consumables
    • 5.1.7 Wound Care Consumables
    • 5.1.8 Dialysis Consumables
    • 5.1.9 Radiology Consumables
    • 5.1.10 Catheters
    • 5.1.11 Other Medical Supplies
  • 5.2 By Application
    • 5.2.1 Urology
    • 5.2.2 Wound Care
    • 5.2.3 Radiology
    • 5.2.4 Respiratory
    • 5.2.5 Infection Control
    • 5.2.6 Cardiology
    • 5.2.7 IVD
    • 5.2.8 Other Applications
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Clinics/Physician Offices
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic plc
    • 6.1.2 Cardinal Health
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Johnson & Johnson Services, Inc.
    • 6.1.5 B. Braun Melsungen AG
    • 6.1.6 Boston Scientific Corporation
    • 6.1.7 Thermo Fisher Scientific, Inc.
    • 6.1.8 Baxter
    • 6.1.9 3M Company
    • 6.1.10 Smith & Nephew
    • 6.1.11 Abbott
    • 6.1.12 Convatec Inc.
    • 6.1.13 Cook Medical
    • 6.1.14 Stryker
    • 6.1.15 Hamilton Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS